Sale disclosed
Sarah Gheuens
Chief Medical Officer
Common stock
- Reported value
- $914.4K
- Reported price
- $30.48 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
AGIOS PHARMACEUTICALS, INC.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 9 trades on this page.
Chief Medical Officer
Common stock
Chief Medical Officer
Common stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Legal Officer
Common stock
Chief Medical Officer
Common stock
Chief Financial Officer
Common stock
Chief Commercial Officer
Common stock
Chief Corp Dev & Strategy
Common stock
Chief Executive Officer
Common stock
Chief Executive Officer
Common stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Medical Officer | Common stockSale10b5-1 | 30,000$30.48 / share | $914.4K | Aug 4Filed Aug 6 · 2d later | SEC filing |
| Chief Medical Officer | Common stockSale10b5-1 | 4,007$37.56 / share | $150.5K | Jul 1Filed Jul 2 · 1d later | SEC filing |
| Chief Legal Officer | Common stockSale10b5-1 | 3,280$34.71 / share | $113.85K | Apr 2Filed Apr 6 · 4d later | SEC filing |
| Chief Medical Officer | Common stockSale10b5-1 | 2,940$34.71 / share | $102.05K | Apr 2Filed Apr 6 · 4d later | SEC filing |
| Chief Financial Officer | Common stockSale10b5-1 | 3,141$34.71 / share | $109.02K | Apr 2Filed Apr 6 · 4d later | SEC filing |
| Chief Commercial Officer | Common stockSale10b5-1 | 3,262$34.71 / share | $113.22K | Apr 2Filed Apr 6 · 4d later | SEC filing |
| Chief Corp Dev & Strategy | Common stockSale10b5-1 | 2,959$34.71 / share | $102.71K | Apr 2Filed Apr 6 · 4d later | SEC filing |
| Chief Executive Officer | Common stockSale10b5-12 trades | 19,068avg $34.71 / share | $661.85K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
Agios Pharmaceuticals, Inc. - Common Stock (AGIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberAgios Pharmaceuticals, Inc. - Common Stock (AGIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberAgios Pharmaceuticals, Inc. - Common Stock (AGIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member